Skip to main content
Top
Published in: Cardiovascular Ultrasound 1/2007

Open Access 01-12-2007 | Research

Exercise training does not improve myocardial diastolic tissue velocities in Type 2 diabetes

Authors: Antti Loimaala, Kaj Groundstroem, Marjo Rinne, Arja Nenonen, Heini Huhtala, Ilkka Vuori

Published in: Cardiovascular Ultrasound | Issue 1/2007

Login to get access

Abstract

Background

Myocardial diastolic tissue velocities are reduced already in newly onset Type 2 diabetes mellitus (T2D). Poor disease control may lead to left ventricular (LV) systolic dysfunction and heart failure. The aim of this study was to assess the effects of exercise training on myocardial diastolic function in T2D patients without ischemic heart disease.

Methods

48 men (52.3 ± 5.6 yrs) with T2D were randomized to supervised training four times a week and standard therapy (E), or standard treatment alone (C) for 12 months. Glycated hemoglobin (HbA1c), oxygen consumption (VO2max), and muscle strength (Sit-up) were measured. Tissue Doppler Imaging (TDI) was used to determine the average maximal mitral annular early (Ea) and late (Aa) diastolic as well as systolic (Sa) velocities, systolic strain (ε) and strain rate (έ) from the septum, and an estimation of left ventricular end diastolic pressure (E/Ea).

Results

Exercise capacity (VO2max, E 32.0 to 34.7 vs. C 32.6 to 31.5 ml/kg/min, p = .001), muscle strength (E 12.7 to 18.3 times vs. C 14.6 to 14.7 times, p < .001), and HbA1c (E 8.2 to 7.5% vs. C 8.0 to 8.4%, p = .006) improved significantly in the exercise group compared to the controls (ANOVA). Systolic blood pressure decreased in the E group (E 144 to 138 mmHg vs. C 146 to 144 mmHg, p = .04). Contrary to risk factor changes diastolic long axis relaxation did not improve significantly, early diastolic velocity Ea from 8.1 to 7.9 cm/s for the E group vs. C 7.4 to 7.8 cm/s (p = .85, ANOVA). Likewise, after 12 months the mitral annular systolic velocity, systolic strain and strain rate, as well as E/Ea were unchanged.

Conclusion

Exercise training improves endurance and muscle fitness in T2D, resulting in better glycemic control and reduced blood pressure. However, myocardial diastolic tissue velocities did not change significantly. Our data suggest that a much longer exercise intervention may be needed in order to reverse diastolic impairment in diabetics, if at all possible.
Appendix
Available only for authorised users
Literature
1.
go back to reference Burchfiel CM, Reed DM, Marcus EB, Strong JP, Hayashi T: Association of diabetes mellitus with coronary aterosclerosis and myocardial lesions: an autopsy study from the Honolulu Heart Program. Am J Epidemiol 1993, 137: 1328-1340.PubMed Burchfiel CM, Reed DM, Marcus EB, Strong JP, Hayashi T: Association of diabetes mellitus with coronary aterosclerosis and myocardial lesions: an autopsy study from the Honolulu Heart Program. Am J Epidemiol 1993, 137: 1328-1340.PubMed
2.
3.
go back to reference The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 1993, 329: 977-986. 10.1056/NEJM199309303291401CrossRef The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 1993, 329: 977-986. 10.1056/NEJM199309303291401CrossRef
4.
go back to reference Rubler S, Dlugash J, Yeceoglu YZ, Kumral T, Branwood AW, Grishman A: New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 1972, 30: 595-602. 10.1016/0002-9149(72)90595-4CrossRefPubMed Rubler S, Dlugash J, Yeceoglu YZ, Kumral T, Branwood AW, Grishman A: New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 1972, 30: 595-602. 10.1016/0002-9149(72)90595-4CrossRefPubMed
5.
go back to reference Loimaala A, Groundstroem K, Majahalme S, Nenonen A, Vuori I: Impaired myocardial function in newly onset Type 2 diabetes associates with arterial stiffness. Eur J Echocardiography 2006,7(5):341-347. 10.1016/j.euje.2005.07.001CrossRef Loimaala A, Groundstroem K, Majahalme S, Nenonen A, Vuori I: Impaired myocardial function in newly onset Type 2 diabetes associates with arterial stiffness. Eur J Echocardiography 2006,7(5):341-347. 10.1016/j.euje.2005.07.001CrossRef
6.
go back to reference Fang ZY, Yuda S, Anderson V, Short L, Case C, Marwick TH: Echocardiographic detection of early diabetic myocardial disease. J Am Coll Cardiol 2003, 41: 611-617. 10.1016/S0735-1097(02)02869-3CrossRefPubMed Fang ZY, Yuda S, Anderson V, Short L, Case C, Marwick TH: Echocardiographic detection of early diabetic myocardial disease. J Am Coll Cardiol 2003, 41: 611-617. 10.1016/S0735-1097(02)02869-3CrossRefPubMed
7.
go back to reference Vinereanu D, Nicolaides E, Boden L, Payne N, Jones CJH, Fraser AG: Conduit arterial stiffness is associated with impaired left ventricular subendocardial function. Heart 2003, 89: 449-451. 10.1136/heart.89.4.449CrossRefPubMedPubMedCentral Vinereanu D, Nicolaides E, Boden L, Payne N, Jones CJH, Fraser AG: Conduit arterial stiffness is associated with impaired left ventricular subendocardial function. Heart 2003, 89: 449-451. 10.1136/heart.89.4.449CrossRefPubMedPubMedCentral
8.
go back to reference Hillis GS, Möller JE, Pellikka PA, Gersh BJ, Wright RS, Ommen SR, Reeder GS, Oh JK: Noninvasive estimation of left ventricular filling pressure by E/e' is a powerful predictor of survival after acute myocardial infarction. J Am Coll Cardiol 2004, 43: 360-367. 10.1016/j.jacc.2003.07.044CrossRefPubMed Hillis GS, Möller JE, Pellikka PA, Gersh BJ, Wright RS, Ommen SR, Reeder GS, Oh JK: Noninvasive estimation of left ventricular filling pressure by E/e' is a powerful predictor of survival after acute myocardial infarction. J Am Coll Cardiol 2004, 43: 360-367. 10.1016/j.jacc.2003.07.044CrossRefPubMed
9.
go back to reference UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS33). Lancet 1998, 352: 837-852. 10.1016/S0140-6736(05)61359-1CrossRef UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS33). Lancet 1998, 352: 837-852. 10.1016/S0140-6736(05)61359-1CrossRef
10.
go back to reference Patel R, Nagueh SF, Tsybouleva N, Abdellatif M, Lutucuta S, Kopelen HA, Quinones MA, Zoghbi WA, Entman ML, Roberts R, Marian AJ: Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circulation 2001, 104: 317-324. 10.1161/hc2801.094031CrossRefPubMedPubMedCentral Patel R, Nagueh SF, Tsybouleva N, Abdellatif M, Lutucuta S, Kopelen HA, Quinones MA, Zoghbi WA, Entman ML, Roberts R, Marian AJ: Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circulation 2001, 104: 317-324. 10.1161/hc2801.094031CrossRefPubMedPubMedCentral
11.
go back to reference Sutherland GR, Stewart MJ, Groundstroem KW, Moran CM, Fleming A, Guell-Peris FJ, Riemersma RA, Fenn LN, Fox KAA, McDicken WN: Color Doppler myocardial imaging: a new technique for the assessment of myocardial function. J Am Soc Echocardiogr 1994, 7: 441-458.CrossRefPubMed Sutherland GR, Stewart MJ, Groundstroem KW, Moran CM, Fleming A, Guell-Peris FJ, Riemersma RA, Fenn LN, Fox KAA, McDicken WN: Color Doppler myocardial imaging: a new technique for the assessment of myocardial function. J Am Soc Echocardiogr 1994, 7: 441-458.CrossRefPubMed
12.
go back to reference World Medical Organization: Declaration of Helsinki. Br Med J 1996, 313: 1448-1449. World Medical Organization: Declaration of Helsinki. Br Med J 1996, 313: 1448-1449.
13.
go back to reference Kirstein P, Carlson K: Determination of the cholesterol content of high density lipoprotein subfractions HDL2 and HDL3, without contamination of Lp(a), in human plasma. Clin Chem Acta 1981,113(2):123-34. 10.1016/0009-8981(81)90146-7CrossRef Kirstein P, Carlson K: Determination of the cholesterol content of high density lipoprotein subfractions HDL2 and HDL3, without contamination of Lp(a), in human plasma. Clin Chem Acta 1981,113(2):123-34. 10.1016/0009-8981(81)90146-7CrossRef
14.
go back to reference Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18: 499-502.PubMed Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18: 499-502.PubMed
15.
go back to reference Schiller NB, Shah PM, Crawford M, et al.: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989, 2: 358-368.CrossRefPubMed Schiller NB, Shah PM, Crawford M, et al.: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989, 2: 358-368.CrossRefPubMed
16.
go back to reference Perez JE, McGill JB, Santiago JV, Schechtman KB, Waggoner AD, Barzilai B, Sobel BE: Abnormal myocardial acoustic properties in diabetic patients and their correlation with the severity of disease. J Am Coll Cardiol 1992, 19: 1154-1162.CrossRefPubMed Perez JE, McGill JB, Santiago JV, Schechtman KB, Waggoner AD, Barzilai B, Sobel BE: Abnormal myocardial acoustic properties in diabetic patients and their correlation with the severity of disease. J Am Coll Cardiol 1992, 19: 1154-1162.CrossRefPubMed
17.
go back to reference Nagueh SF, Bachincski LL, Meyer D, Hill R, Zoghbi WA, Tam JW, Quinones MA, Roberts R, Marian AJ: Tissue doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation 2001,104(2):128-130.CrossRefPubMedPubMedCentral Nagueh SF, Bachincski LL, Meyer D, Hill R, Zoghbi WA, Tam JW, Quinones MA, Roberts R, Marian AJ: Tissue doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation 2001,104(2):128-130.CrossRefPubMedPubMedCentral
18.
go back to reference Lehto S, Pyörälä K, Miettinen H, Rönnemaa T, Palomäki P, Tuomilehto J, Laakso M: Myocardial infarct size and mortality in patients with non-insulin dependent diabetes mellitus. J Intern Med 1994, 236: 291-297.CrossRefPubMed Lehto S, Pyörälä K, Miettinen H, Rönnemaa T, Palomäki P, Tuomilehto J, Laakso M: Myocardial infarct size and mortality in patients with non-insulin dependent diabetes mellitus. J Intern Med 1994, 236: 291-297.CrossRefPubMed
19.
go back to reference Fletcher GF, Balady G, Blair SN, Blumenthal J, Caspersen C, Chaitman B, Epstein S, Froelicher ESJ, Froelicher VF, Pina IL, Pollock ML: Statement on exercise: Benefits and recommendations for physical activity programs for all Americans. Circulation 1996, 94: 857-862.CrossRefPubMed Fletcher GF, Balady G, Blair SN, Blumenthal J, Caspersen C, Chaitman B, Epstein S, Froelicher ESJ, Froelicher VF, Pina IL, Pollock ML: Statement on exercise: Benefits and recommendations for physical activity programs for all Americans. Circulation 1996, 94: 857-862.CrossRefPubMed
20.
go back to reference Hull SS, Vanoli E, Adamson PB, Verrier RL, Foreman RD, Schwartz PJ: Exercise training confers anticipatory protection from sudden death during acute myocardial ischemia. Circulation 1994, 89: 548-552.CrossRefPubMed Hull SS, Vanoli E, Adamson PB, Verrier RL, Foreman RD, Schwartz PJ: Exercise training confers anticipatory protection from sudden death during acute myocardial ischemia. Circulation 1994, 89: 548-552.CrossRefPubMed
21.
go back to reference Sylvén C, Sarkar N, Rück A, Drvota V, Y-Hassa S, Lind B, Nygren A, Källner G, Blomberg P, van der Linden J, Lindblom D, Brodin LÅ, Islam KB: Myocardial Doppler tissue velocity improves following myocardial gene therapy with VEGF-A 165 plasmid in patients with inoperable angina pectoris. Coron Artery Dis 2001, 12: 239-243. 10.1097/00019501-200105000-00010CrossRefPubMed Sylvén C, Sarkar N, Rück A, Drvota V, Y-Hassa S, Lind B, Nygren A, Källner G, Blomberg P, van der Linden J, Lindblom D, Brodin LÅ, Islam KB: Myocardial Doppler tissue velocity improves following myocardial gene therapy with VEGF-A 165 plasmid in patients with inoperable angina pectoris. Coron Artery Dis 2001, 12: 239-243. 10.1097/00019501-200105000-00010CrossRefPubMed
22.
go back to reference Loimaala A, Huikuri HV, Kööbi T, Rinne M, Nenonen A, Vuori I: Exercise training improves baroreflex sensitivity in Type II diabetic men. Diabetes 2003, 52: 1837-1842. 10.2337/diabetes.52.7.1837CrossRefPubMed Loimaala A, Huikuri HV, Kööbi T, Rinne M, Nenonen A, Vuori I: Exercise training improves baroreflex sensitivity in Type II diabetic men. Diabetes 2003, 52: 1837-1842. 10.2337/diabetes.52.7.1837CrossRefPubMed
23.
go back to reference Weidemann F, Breinig F, Beer M, Sandstede J, Turschner O, Voelker W, Ertl G, Knoll A, Wanner C, Strotmann JM: Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease. A prospective strain rate imaging study. Circulation 2003, 108: 1299-1301. 10.1161/01.CIR.0000091253.71282.04CrossRefPubMed Weidemann F, Breinig F, Beer M, Sandstede J, Turschner O, Voelker W, Ertl G, Knoll A, Wanner C, Strotmann JM: Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease. A prospective strain rate imaging study. Circulation 2003, 108: 1299-1301. 10.1161/01.CIR.0000091253.71282.04CrossRefPubMed
24.
go back to reference Hansen A, Johansson B-L, Wahren J, von Bibra H: C-peptide exerts beneficial effects on myocardial blod flow and function in patients with type 1 diabetes. Diabetes 2002, 51: 3077-3082. 10.2337/diabetes.51.10.3077CrossRefPubMed Hansen A, Johansson B-L, Wahren J, von Bibra H: C-peptide exerts beneficial effects on myocardial blod flow and function in patients with type 1 diabetes. Diabetes 2002, 51: 3077-3082. 10.2337/diabetes.51.10.3077CrossRefPubMed
25.
go back to reference Amos AF, McCarty DJ, Zimmeth P: The rising global burden of diabetes and its complications: Estimates and projections to the year 2010. Diabet Med 1997,14(Suppl 5):S1-S85.10.1002/(SICI)1096-9136(199712)14:5+<S7::AID-DIA522>3.3.CO;2-IPubMed Amos AF, McCarty DJ, Zimmeth P: The rising global burden of diabetes and its complications: Estimates and projections to the year 2010. Diabet Med 1997,14(Suppl 5):S1-S85.10.1002/(SICI)1096-9136(199712)14:5+<S7::AID-DIA522>3.3.CO;2-IPubMed
26.
go back to reference Tuomilehto J, Lindström J, Erikson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344: 1343-1350. 10.1056/NEJM200105033441801CrossRefPubMed Tuomilehto J, Lindström J, Erikson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344: 1343-1350. 10.1056/NEJM200105033441801CrossRefPubMed
27.
go back to reference Laakso M, Lehto S: Epidemiology of macrovascular disease in diabetes. Diabet Rev 1997, 5: 294-315. Laakso M, Lehto S: Epidemiology of macrovascular disease in diabetes. Diabet Rev 1997, 5: 294-315.
28.
go back to reference Gwilt DJ, Petri M, Lewis PW, Nattrass M, Pentecost BL: Myocardial infarct size and mortality in diabetic subjects. Br Heart J 1985, 54: 466-472. 10.1136/hrt.54.5.466CrossRefPubMedPubMedCentral Gwilt DJ, Petri M, Lewis PW, Nattrass M, Pentecost BL: Myocardial infarct size and mortality in diabetic subjects. Br Heart J 1985, 54: 466-472. 10.1136/hrt.54.5.466CrossRefPubMedPubMedCentral
29.
go back to reference Liebson PR, Grandits GA, Dianzumba S, Prineas RJ, Grimm RH Jr, Neaton JD, Stamler J, for the Treatment of Hypertension Study Research Group: Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS). Circulation 1995, 91: 698-706.CrossRefPubMed Liebson PR, Grandits GA, Dianzumba S, Prineas RJ, Grimm RH Jr, Neaton JD, Stamler J, for the Treatment of Hypertension Study Research Group: Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS). Circulation 1995, 91: 698-706.CrossRefPubMed
Metadata
Title
Exercise training does not improve myocardial diastolic tissue velocities in Type 2 diabetes
Authors
Antti Loimaala
Kaj Groundstroem
Marjo Rinne
Arja Nenonen
Heini Huhtala
Ilkka Vuori
Publication date
01-12-2007
Publisher
BioMed Central
Published in
Cardiovascular Ultrasound / Issue 1/2007
Electronic ISSN: 1476-7120
DOI
https://doi.org/10.1186/1476-7120-5-32

Other articles of this Issue 1/2007

Cardiovascular Ultrasound 1/2007 Go to the issue